Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to SARS-CoV-2 Infection

NCT04556864 is registered in ClinicalTrials.gov with Juan Victor Lorente as lead sponsor.

NCT NCT04556864
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04556864 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to SARS-CoV-2 Infection
Lead sponsor
Juan Victor Lorente
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2020
Completion date
April 1, 2021
Enrollment
67 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

ards, human, covid19, hemodynamic instability